Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture

FEBS Lett. 1993 Dec 27;336(2):215-20. doi: 10.1016/0014-5793(93)80806-6.

Abstract

Interleukin 4 (IL4) has been shown to exhibit anti-inflammatory effects by inhibiting the secretion by monocytes of proinflammatory cytokines such as interleukin 1 (IL1), interleukin 6 (IL6), and tumor necrosis factor (TNF) and by inducing the secretion of the IL1 receptor antagonist. We investigated the role of this cytokine on the production of acute-phase proteins in primary human hepatocyte cultures. Cells were exposed to either IL4 and/or IL6, the most potent mediator of hepatic acute phase proteins. IL4 led to decreased production of haptoglobin, C-reactive protein and albumin while alpha 1-antitrypsin and fibrinogen remained unaffected. These inhibitory effects of IL4 were also observed at the mRNA level. In addition, IL4 inhibited the IL6-induced production of haptoglobin although it had no effect on the induced C-reactive protein and fibrinogen. Our results demonstrate that IL4 can affect the production of a subset of acute-phase proteins by human hepatocytes and can antagonize some of the effects of IL6. These observations reinforce the notion that IL4 can be considered as an anti-inflammatory cytokine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Proteins / biosynthesis*
  • Acute-Phase Proteins / genetics
  • Cells, Cultured
  • Female
  • Humans
  • Interleukin-4 / pharmacology*
  • Interleukin-6 / pharmacology
  • Liver / cytology
  • Liver / drug effects*
  • Liver / metabolism
  • Male
  • RNA, Messenger / metabolism

Substances

  • Acute-Phase Proteins
  • Interleukin-6
  • RNA, Messenger
  • Interleukin-4